| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |